Cheng K C, Moss B
J Virol. 1987 Apr;61(4):1286-90. doi: 10.1128/JVI.61.4.1286-1290.1987.
Selective synthesis in mammalian cells of the hepatitis B virus middle surface (MS) protein, which is 55 amino acids longer than the major surface (S) protein, was achieved by using a recombinant vaccinia virus. The 33-kilodalton MS polypeptide was glycosylated and secreted as particles that resembled human hepatitis B surface antigen as well as particles composed solely of S protein with regard to antigenicity, buoyant density, size, and electron micrographic appearance. The MS particles differed from S particles, however, by binding to polymerized human albumin and inducing antibodies that reacted with a pre-S peptide and inhibited the binding of human plasma-derived hepatitis B surface antigen to polymerized human albumin.
利用重组痘苗病毒在哺乳动物细胞中实现了乙型肝炎病毒中表面(MS)蛋白的选择性合成,该蛋白比主要表面(S)蛋白长55个氨基酸。33千道尔顿的MS多肽发生糖基化并作为颗粒分泌,这些颗粒在抗原性、浮力密度、大小和电子显微镜外观方面类似于人乙型肝炎表面抗原以及仅由S蛋白组成的颗粒。然而,MS颗粒与S颗粒不同,它能结合聚合的人白蛋白并诱导与前S肽反应的抗体,且能抑制人血浆来源的乙型肝炎表面抗原与聚合的人白蛋白的结合。